Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women

Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women

Abstract Background The determination of foetal Rhesus D (RHD) status allows appropriate use of IgRh prophylaxis by restricting its use to cases of RHD feto-maternal incompatibilities. There is a degree of uncertainty about the cost-effectiveness of foetal RHD determination, yet screening programs a...

Full description

Bibliographic Details
Main Authors: Meryl Darlington, Bruno Carbonne, Agnès Mailloux, Yves Brossard, Annie Levy-Mozziconacci, Anne Cortey, Hassani Maoulida, Tabassome Simon, Alexandra Rousseau, Isabelle Durand-Zaleski, the GENIFERH1 Study Group
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Pregnancy and Childbirth
Subjects:
Anti-D immunoglobulin
Non-invasive foetal RHD genotyping
Cost evaluation
Cost-effectiveness
Online Access:http://link.springer.com/article/10.1186/s12884-018-2114-5

Internet

http://link.springer.com/article/10.1186/s12884-018-2114-5

Similar Items